Experts' Perspective: Top Cardiology News from ACC 23
Deepak Bhatt, MD, MPH, and Gregg Stone, MD, offer perspective on the top cardiology news presented at the American College of Cardiology’s 2023 Annual Scientific Session. Dr. Bhatt said, “There is a lot of good data at the conference, but since you asked for just one, I'll answer the question unlike many others who list multiple things. I think Dr. Paul Ridker's presentation on a pooled analysis from the PROMINENT, REDUCE-IT, and STRENGTH trials was the most interesting. The analysis focused on residual inflammatory risk, which is a well-known concept, but Dr. Ridker examined the residual risk attributed to inflammation, which was a very clever analysis. Dr. Pradhan contributed data from PROMINENT, Dr. Nissen from STRENGTH, and I contributed from REDUCE-IT. Dr. Ridker found that there is a substantial risk attributable to inflammation even if cholesterol is well controlled with good statin therapy, indicating a need for therapies directed towards inflammation to reduce cardiovascular event rates. Ongoing trials will shed more light on this, but this analysis bodes well for that series of trials.”
.jpg)
New Treatment Approach for Advanced Coronary Artery Disease Leads to Improved Outcomes
Nov 04, 2021 View All Press Releases